154 related articles for article (PubMed ID: 37857042)
1. Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration.
Bhat AD; Keasler PM; Kolluru L; Dombrowski MM; Palanisamy A; Singh PM
Pregnancy Hypertens; 2023 Dec; 34():74-82. PubMed ID: 37857042
[TBL] [Abstract][Full Text] [Related]
2. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Bellos I; Pergialiotis V; Papapanagiotou A; Loutradis D; Daskalakis G
Am J Obstet Gynecol; 2020 Oct; 223(4):525-537. PubMed ID: 32199925
[TBL] [Abstract][Full Text] [Related]
4. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Sridharan K; Sequeira RP
Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
Abalos E; Duley L; Steyn DW; Gialdini C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
[TBL] [Abstract][Full Text] [Related]
8. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Liu QQ; Yu YH; Gong SP; Huang LP
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):592-7. PubMed ID: 23141179
[TBL] [Abstract][Full Text] [Related]
10. PP088. Oral antihypertensive therapy for severe hypertension in pregnancy.
Firoz T; Magee LA; Lalani S; Sawchuck D; Payne B; Vidler M; Gordon R; von Dadelszen P;
Pregnancy Hypertens; 2012 Jul; 2(3):288. PubMed ID: 26105410
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
S D; Novri DA; Hamidy Y; Savira M
F1000Res; 2022; 11():1287. PubMed ID: 37273965
[No Abstract] [Full Text] [Related]
12. Calcium channel blockers for inhibiting preterm labour and birth.
Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical administration for severe hypertension during pregnancy: Network meta-analysis.
Deng NJ; Xian-Yu CY; Han RZ; Huang CY; Ma YT; Li HJ; Gao TY; Liu X; Zhang C
Front Pharmacol; 2022; 13():1092501. PubMed ID: 36699058
[No Abstract] [Full Text] [Related]
14. Antihypertensive drugs in pregnancy.
Naden RP; Redman CW
Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of postpartum hypertension.
Magee L; von Dadelszen P
Cochrane Database Syst Rev; 2013 Apr; (4):CD004351. PubMed ID: 23633317
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
Aali BS; Nejad SS
Acta Obstet Gynecol Scand; 2002 Jan; 81(1):25-30. PubMed ID: 11942883
[TBL] [Abstract][Full Text] [Related]
17. Anti-hypertensive therapy for preeclampsia: a network meta-analysis and systematic review.
Wang T; Jiang R; Yao Y; Xu T; Li N
Hypertens Pregnancy; 2024 Dec; 43(1):2329068. PubMed ID: 38488570
[TBL] [Abstract][Full Text] [Related]
18. Oral nifedipine therapy in the management of severe preeclampsia.
Kwawukume EY; Ghosh TS
Int J Gynaecol Obstet; 1995 Jun; 49(3):265-9. PubMed ID: 9764864
[TBL] [Abstract][Full Text] [Related]
19. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
[TBL] [Abstract][Full Text] [Related]
20. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Hussein M; Mooij JM; Roujouleh H
Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
